FI953371A0 - TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi - Google Patents

TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi

Info

Publication number
FI953371A0
FI953371A0 FI953371A FI953371A FI953371A0 FI 953371 A0 FI953371 A0 FI 953371A0 FI 953371 A FI953371 A FI 953371A FI 953371 A FI953371 A FI 953371A FI 953371 A0 FI953371 A0 FI 953371A0
Authority
FI
Finland
Prior art keywords
preparing
virus infections
immunization against
tbe virus
against tbe
Prior art date
Application number
FI953371A
Other languages
English (en)
Swedish (sv)
Other versions
FI117974B (fi
FI953371A (fi
Inventor
Franz Xaver Heinz
Steven Allison
Christian Mandl
Christian Kunz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0135294A external-priority patent/AT402897B/de
Priority claimed from AT0087195A external-priority patent/AT405607B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI953371A0 publication Critical patent/FI953371A0/fi
Publication of FI953371A publication Critical patent/FI953371A/fi
Application granted granted Critical
Publication of FI117974B publication Critical patent/FI117974B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24161Methods of inactivation or attenuation
    • C12N2770/24162Methods of inactivation or attenuation by genetic engineering
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI953371A 1994-07-08 1995-07-07 Parannettu rokote immunisointiin TBE-virusinfektioita vastaan ja menetelmä sen valmistamiseksi FI117974B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT0135294A AT402897B (de) 1994-07-08 1994-07-08 Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung
AT135294 1994-07-08
AT0087195A AT405607B (de) 1995-05-23 1995-05-23 Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung
AT87195 1995-05-23

Publications (3)

Publication Number Publication Date
FI953371A0 true FI953371A0 (fi) 1995-07-07
FI953371A FI953371A (fi) 1996-01-09
FI117974B FI117974B (fi) 2007-05-15

Family

ID=25594155

Family Applications (2)

Application Number Title Priority Date Filing Date
FI953371A FI117974B (fi) 1994-07-08 1995-07-07 Parannettu rokote immunisointiin TBE-virusinfektioita vastaan ja menetelmä sen valmistamiseksi
FI20070041A FI118222B (fi) 1994-07-08 2007-01-17 Parannettu rokote Flavivirusinfektioiden vastaiseen immunisointiin

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20070041A FI118222B (fi) 1994-07-08 2007-01-17 Parannettu rokote Flavivirusinfektioiden vastaiseen immunisointiin

Country Status (9)

Country Link
EP (2) EP0869184B1 (fi)
AT (2) ATE198909T1 (fi)
CZ (1) CZ282927B6 (fi)
DE (2) DE59509667D1 (fi)
DK (2) DK0869184T3 (fi)
ES (2) ES2165109T3 (fi)
FI (2) FI117974B (fi)
HU (2) HU219503B (fi)
RU (1) RU2150294C1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833388D1 (de) * 1997-11-20 2006-04-13 Us Army Medical Res Materiel C Dna impfstoffe gegen zecken-flavivieren
US7425437B2 (en) 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
EP1572941A4 (en) * 2002-02-26 2009-03-18 Maxygen Inc NEW FLAVIVIRUS ANTIGENES
CA2591665C (en) 2004-12-20 2015-05-05 Crucell Holland B.V. Binding molecules capable of neutralizing west nile virus and uses thereof
US8052974B2 (en) 2005-05-12 2011-11-08 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
US8211431B2 (en) 2006-06-06 2012-07-03 Crucell Holland B.V. Human binding molecules having killing activity against staphylococci and uses thereof
WO2010008411A1 (en) 2007-11-09 2010-01-21 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074422T3 (es) * 1987-03-20 1995-09-16 Immuno Ag Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
WO1992003161A1 (en) 1990-08-27 1992-03-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
DK0584348T3 (da) 1992-03-11 2005-09-19 Powderject Vaccines Inc Genetisk vaccine mod immundefektvirusser

Also Published As

Publication number Publication date
DK0869184T3 (da) 2001-12-17
HU9903233D0 (en) 1999-11-29
CZ176995A3 (en) 1996-01-17
EP0869184A3 (de) 1999-05-12
HU219503B (hu) 2001-04-28
DK0691404T3 (da) 2001-03-19
RU2150294C1 (ru) 2000-06-10
DE59509667D1 (de) 2001-11-08
EP0691404B1 (de) 2001-01-24
EP0869184B1 (de) 2001-10-04
HU9501832D0 (en) 1995-08-28
CZ282927B6 (cs) 1997-11-12
FI117974B (fi) 2007-05-15
ES2165109T3 (es) 2002-03-01
ATE198909T1 (de) 2001-02-15
HU224199B1 (hu) 2005-06-28
FI20070041A (fi) 2007-01-17
ES2155510T3 (es) 2001-05-16
EP0691404A2 (de) 1996-01-10
FI118222B (fi) 2007-08-31
FI953371A (fi) 1996-01-09
ATE206459T1 (de) 2001-10-15
EP0869184A2 (de) 1998-10-07
HUT72395A (en) 1996-04-29
DE59508988D1 (de) 2001-03-01
EP0691404A3 (de) 1997-11-12

Similar Documents

Publication Publication Date Title
SE9003978D0 (sv) Dna expressionssystem baserade paa ett virus replikon
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
CY1105600T1 (el) Κατασκευασματα νουκλεϊκων οξεων για γενετικη ανοσοποιηση
FI20070041A (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
CY1106350T1 (el) Εμβολιο φυματιωσης
DK606285D0 (da) Vaccine mod rabies samt fremgangsmaade til fremstilling deraf
DK457687A (da) Antigenisk aktive proteiner og peptider, og vacciner mod virus for felin peritonitis (fipv) med indhold af saadanne proteiner eller peptider
NO902251L (no) Fremstilling av gonoreiske p1-proteiner og vaksiner.
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
NO910279L (no) Eimeria overflateantigen samt coccidiosevaksine inneholdende slike.
DE68923006D1 (de) Fusionsproteine der untereinheit b von choleratoxin und eines heterologen antigens und dafür kodierende rekombinante nukleinsäure.
IL82720A0 (en) Recombinant polypeptide containing the amino acid sequence of the protein of feline leukemia virus,expression vehicles,plasmids coding for said protein,method for production thereof and pharmaceutical compositions
NO20041564L (no) Infeksios lakse anemi-virus vaksine
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
IL88622A0 (en) Dna sequences which code for an antigenic protein,antigens coded for by said dna sequences and a vaccine and method for protecting birds using the same
AU686000B2 (en) Infectious peritonitis vaccine
PT729509E (pt) Vacina contra papeira contendo uma estirpe do virus jerryl-lynn
DK0514411T3 (da) Polypeptider og DNA, som koder for disse, associeret med humane malariaparasitter
FI861559A0 (fi) Menetelmä hepatitis B-viruksen pinta-antigeenin PreS1-PreS2-S-proteiinin koodaavan alueen koodaamia proteiineja käsittävän proteiinin valmistamiseksi sekä menetelmässä käytettävät yhdistelmä-DNA-vektorit ja -kontameerit sekä nisäkässolut

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117974

Country of ref document: FI

MM Patent lapsed